Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	protein K29-linked ubiquitination	UBE2D2 UBE2D3 UBR5 RNF126	5.84e-06	13	201	4	GO:0035519
Domain	DUF1785	AGO2 AGO4 PIWIL2	1.23e-05	5	202	3	SM01163
Domain	ArgoL1	AGO2 AGO4 PIWIL2	2.43e-05	6	202	3	PF08699
Domain	ArgoL1	AGO2 AGO4 PIWIL2	2.43e-05	6	202	3	IPR014811
Domain	Poly(ADP-ribose)pol_cat_dom	PARP6 PARP1 PARP4 PARP8	2.83e-05	17	202	4	IPR012317
Domain	PARP_CATALYTIC	PARP6 PARP1 PARP4 PARP8	2.83e-05	17	202	4	PS51059
Domain	PARP	PARP6 PARP1 PARP4 PARP8	2.83e-05	17	202	4	PF00644
Domain	-	PARP6 PARP1 PARP4 PARP8	2.83e-05	17	202	4	3.90.228.10
Domain	PIWI	AGO2 AGO4 PIWIL2	6.71e-05	8	202	3	PS50822
Domain	Piwi	AGO2 AGO4 PIWIL2	6.71e-05	8	202	3	SM00950
Domain	Piwi	AGO2 AGO4 PIWIL2	6.71e-05	8	202	3	PF02171
Domain	Piwi	AGO2 AGO4 PIWIL2	6.71e-05	8	202	3	IPR003165
Domain	PAZ	AGO2 AGO4 PIWIL2	9.98e-05	9	202	3	PS50821
Domain	PAZ	AGO2 AGO4 PIWIL2	9.98e-05	9	202	3	SM00949
Domain	PAZ	AGO2 AGO4 PIWIL2	9.98e-05	9	202	3	PF02170
Domain	PAZ_dom	AGO2 AGO4 PIWIL2	9.98e-05	9	202	3	IPR003100
Domain	Pumilio_RNA-bd	PUM2 PUM1	1.16e-04	2	202	2	IPR033712
Domain	WGR_domain	PARP6 PARP1 PARP4 PARP8	1.19e-04	24	202	4	IPR008893
Domain	EGF_dom	NELL1 STAB2 CUBN	2.55e-04	12	202	3	IPR024731
Domain	EGF_3	NELL1 STAB2 CUBN	2.55e-04	12	202	3	PF12947
Domain	PUF	PUM2 PUM1	3.47e-04	3	202	2	PF00806
Domain	PUM_HD	PUM2 PUM1	3.47e-04	3	202	2	PS50303
Domain	PUM-HD	PUM2 PUM1	3.47e-04	3	202	2	IPR033133
Domain	FAS1	STAB2 POSTN	6.88e-04	4	202	2	SM00554
Domain	FAS1_domain	STAB2 POSTN	6.88e-04	4	202	2	IPR000782
Domain	PARP_ALPHA_HD	PARP1 PARP4	6.88e-04	4	202	2	PS51060
Domain	Poly(ADP-ribose)pol_reg_dom	PARP1 PARP4	6.88e-04	4	202	2	IPR004102
Domain	PUM	PUM2 PUM1	6.88e-04	4	202	2	PS50302
Domain	Pumilio_RNA-bd_rpt	PUM2 PUM1	6.88e-04	4	202	2	IPR001313
Domain	-	PARP1 PARP4	6.88e-04	4	202	2	1.20.142.10
Domain	Argonaute_N	AGO2 AGO4	6.88e-04	4	202	2	IPR032474
Domain	Argonaute_Mid_dom	AGO2 AGO4	6.88e-04	4	202	2	IPR032473
Domain	ArgoL2	AGO2 AGO4	6.88e-04	4	202	2	IPR032472
Domain	-	STAB2 POSTN	6.88e-04	4	202	2	2.30.180.10
Domain	FAS1	STAB2 POSTN	6.88e-04	4	202	2	PS50213
Domain	Fasciclin	STAB2 POSTN	6.88e-04	4	202	2	PF02469
Domain	ArgoN	AGO2 AGO4	6.88e-04	4	202	2	PF16486
Domain	ArgoMid	AGO2 AGO4	6.88e-04	4	202	2	PF16487
Domain	ArgoL2	AGO2 AGO4	6.88e-04	4	202	2	PF16488
Domain	Pumilio	PUM2 PUM1	6.88e-04	4	202	2	SM00025
Domain	RUN	DENND5B RUNDC1 RUBCN	9.02e-04	18	202	3	SM00593
Domain	-	PLPPR3 PLPPR4 G6PC3	9.02e-04	18	202	3	1.20.144.10
Domain	acidPPc	PLPPR3 PLPPR4 G6PC3	9.02e-04	18	202	3	SM00014
Domain	RUN	DENND5B RUNDC1 RUBCN	1.06e-03	19	202	3	PS50826
Domain	RUN	DENND5B RUNDC1 RUBCN	1.06e-03	19	202	3	PF02759
Domain	Run_dom	DENND5B RUNDC1 RUBCN	1.06e-03	19	202	3	IPR004012
Domain	EGF	RELN NELL1 FCGBP STAB2 EFEMP2 NTNG1 CUBN SLIT3 LRP1	1.07e-03	235	202	9	SM00181
Domain	P_Acid_Pase_2/haloperoxidase	PLPPR3 PLPPR4 G6PC3	1.24e-03	20	202	3	IPR000326
Domain	PAP2	PLPPR3 PLPPR4 G6PC3	1.24e-03	20	202	3	PF01569
Domain	Growth_fac_rcpt_	ERBB2 NELL1 STAB2 EFEMP2 CUBN SLIT3 LRP1	1.56e-03	156	202	7	IPR009030
Domain	EGF-like_dom	RELN NELL1 FCGBP STAB2 EFEMP2 NTNG1 CUBN SLIT3 LRP1	1.60e-03	249	202	9	IPR000742
Domain	PH_BEACH	LYST NBEAL2	1.70e-03	6	202	2	PF14844
Pubmed	Antagonistic and cooperative AGO2-PUM interactions in regulating mRNAs.	AGO2 PUM2 PUM1	2.14e-07	3	209	3	30333515
Pubmed	The mammalian TRIM-NHL protein TRIM71/LIN-41 is a repressor of mRNA function.	AGO2 XRN1 PUM2 PUM1	2.59e-07	10	209	4	23125361
Pubmed	HIV-1 Vpr protein inhibits telomerase activity via the EDD-DDB1-VPRBP E3 ligase complex.	UBE2D2 UBR5 TERT	2.12e-06	5	209	3	23612978
Pubmed	Family-wide analysis of poly(ADP-ribose) polymerase activity.	PARP6 PARP1 PARP4 PARP8	2.18e-06	16	209	4	25043379
Pubmed	A ubiquitin ligase complex assembles linear polyubiquitin chains.	UBE2D2 UBE2D3 RNF31	7.36e-06	7	209	3	17006537
Pubmed	Cooperation of HECT-domain ubiquitin ligase hHYD and DNA topoisomerase II-binding protein for DNA damage response.	UBE2D2 UBE2D3 UBR5	7.36e-06	7	209	3	11714696
Pubmed	Hypoxia regulates overall mRNA homeostasis by inducing Met1-linked linear ubiquitination of AGO2 in cancer cells.	AGO2 UBE2D3 RNF31	7.36e-06	7	209	3	34518544
Pubmed	Bifunctional apoptosis regulator (BAR), an endoplasmic reticulum (ER)-associated E3 ubiquitin ligase, modulates BI-1 protein stability and function in ER Stress.	UBE2D2 UBE2D3 UBE2G2	7.36e-06	7	209	3	21068390
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP20 ZNF462 LRIG2 PARP4 TNRC18 MYO15B POM121 NTNG1 MAGI3 CGNL1 SPIDR CDC5L DOP1A	1.02e-05	493	209	13	15368895
Pubmed	Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis.	AGO2 AGO4 PIWIL2	1.17e-05	8	209	3	19345100
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ERBB2 AGO2 ATRX VPS13C OBSCN ADCY1 ZNF462 TNRC18 INTS2 TLE5 SMYD3 MRPL42 RALGAPB MAGI3 CPT1A INTS8 SBNO2 DNAH1 LATS2 GALNT11 LRP1 SPIDR KDM4B DOP1A	1.18e-05	1489	209	24	28611215
Pubmed	Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging.	UBA7 UBE2D2 UBE2D3 UBE2G2	1.45e-05	25	209	4	17597759
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	AGO2 VPS13C P4HA3 TMEM214 POLR1F PARP1 FASN POM121 HIBCH UBR5 MTCH2 DHX37 NOL9 ARAF DCHS1 PUM1	1.49e-05	754	209	16	35906200
Pubmed	The DNA sequence of human chromosome 7.	MOXD2P RELN CPED1 ADCY1 SEMA3A TNRC18 POM121 CLCN1 ZMIZ2 ANKRD61 GALNT11 ASB4	1.66e-05	441	209	12	12853948
Pubmed	Inhibition of Poly(ADP-Ribose) Polymerase-1 Protects Chronic Alcoholic Liver Injury.	PARP1 FASN CPT1A	1.75e-05	9	209	3	27746183
Pubmed	Identification of eight members of the Argonaute family in the human genome.	AGO2 AGO4 PIWIL2	1.75e-05	9	209	3	12906857
Pubmed	Targeting ubiquitin conjugating enzyme UbcH5b by a triterpenoid PC3-15 from Schisandra plants sensitizes triple-negative breast cancer cells to lapatinib.	UBE2D2 UBE2D3 RNF126	2.49e-05	10	209	3	33607208
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	ADGRB3 PLPPR3 PLPPR4 PCDH19 MAP3K10 ANK2 FASTKD1 MAGI3	2.75e-05	197	209	8	36604605
Pubmed	Thrombin promotes sustained signaling and inflammatory gene expression through the CDC25 and Ras-associating domains of phospholipase Cϵ.	F2 PLCE1	3.59e-05	2	209	2	26350460
Pubmed	Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors.	ERBB2 PARP1	3.59e-05	2	209	2	28031413
Pubmed	Cloning and comparative sequence analysis of PUM1 and PUM2 genes, human members of the Pumilio family of RNA-binding proteins.	PUM2 PUM1	3.59e-05	2	209	2	12459267
Pubmed	Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins.	PUM2 PUM1	3.59e-05	2	209	2	29165587
Pubmed	Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs.	ERBB2 FASN	3.59e-05	2	209	2	26107737
Pubmed	PUMILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.	PUM2 PUM1	3.59e-05	2	209	2	35507203
Pubmed	Mouse Pum1 and Pum2 genes, members of the Pumilio family of RNA-binding proteins, show differential expression in fetal and adult hematopoietic stem cells and progenitors.	PUM2 PUM1	3.59e-05	2	209	2	12667987
Pubmed	Regulation of telomerase by telomeric proteins.	DKC1 TERT	3.59e-05	2	209	2	15189140
Pubmed	A Quantitative and Predictive Model for RNA Binding by Human Pumilio Proteins.	PUM2 PUM1	3.59e-05	2	209	2	31078383
Pubmed	Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.	ERBB2 FASN	3.59e-05	2	209	2	27714708
Pubmed	Involvement of poly(ADP-ribose) polymerase 1 in ERBB2 expression in rheumatoid synovial cells.	ERBB2 PARP1	3.59e-05	2	209	2	15743888
Pubmed	Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity.	ERBB2 POSTN	3.59e-05	2	209	2	25592291
Pubmed	Biophysical and biological evaluation of optimized stapled peptide inhibitors of the linear ubiquitin chain assembly complex (LUBAC).	UBE2D3 RNF31	3.59e-05	2	209	2	29246782
Pubmed	A dyskerin motif reactivates telomerase activity in X-linked dyskeratosis congenita and in telomerase-deficient human cells.	DKC1 TERT	3.59e-05	2	209	2	18057229
Pubmed	TLT-1s, alternative transcripts of triggering receptor expressed on myeloid cell-like transcript-1 (TLT-1), Inhibits the triggering receptor expressed on myeloid cell-2 (TREM-2)-mediated signaling pathway during osteoclastogenesis.	TREML1 TREM2	3.59e-05	2	209	2	22761415
Pubmed	Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.	PARP1 TLR2	3.59e-05	2	209	2	19684606
Pubmed	Characterization of RNP Networks of PUM1 and PUM2 Post-Transcriptional Regulators in TCam-2 Cells, a Human Male Germ Cell Model.	PUM2 PUM1	3.59e-05	2	209	2	32316190
Pubmed	TERT-mediated and ATRX-mediated Telomere Maintenance and Neuroblastoma.	ATRX TERT	3.59e-05	2	209	2	28452859
Pubmed	A family with Hoyeraal-Hreidarsson syndrome and four variants in two genes of the telomerase core complex.	DKC1 TERT	3.59e-05	2	209	2	23335200
Pubmed	Defects in mTR stability and telomerase activity produced by the Dkc1 A353V mutation in dyskeratosis congenita are rescued by a peptide from the dyskerin TruB domain.	DKC1 TERT	3.59e-05	2	209	2	22855157
Pubmed	Triple-negative breast cancer.	ERBB2 PARP1	3.59e-05	2	209	2	20473728
Pubmed	Genome-wide comparison of human keratinocyte and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer.	PUM2 PUM1	3.59e-05	2	209	2	12771951
Pubmed	Poly-(ADP-Ribose) Polymerase-1 Promotes Prothrombin Gene Transcription and Produces Des-Gamma-Carboxy Prothrombin in Hepatocellular Carcinoma.	F2 PARP1	3.59e-05	2	209	2	28384634
Pubmed	Embryonic Lethality in Homozygous Human Her-2 Transgenic Mice Due to Disruption of the Pds5b Gene.	PDS5B ERBB2	3.59e-05	2	209	2	26334628
Pubmed	FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration.	ERBB2 FASN	3.59e-05	2	209	2	26936618
Pubmed	MicroRNA-1224 Splicing CircularRNA-Filip1l in an Ago2-Dependent Manner Regulates Chronic Inflammatory Pain via Targeting Ubr5.	AGO2 UBR5	3.59e-05	2	209	2	30651325
Pubmed	Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer.	ERBB2 FASN	3.59e-05	2	209	2	25433947
Pubmed	Comparative analysis of mRNA targets for human PUF-family proteins suggests extensive interaction with the miRNA regulatory system.	PUM2 PUM1	3.59e-05	2	209	2	18776931
Pubmed	Paracoccidioides brasiliensis downmodulates α3 integrin levels in human lung epithelial cells in a TLR2-dependent manner.	ITGA3 TLR2	3.59e-05	2	209	2	33173103
Pubmed	Bespoke RNA recognition by Pumilios.	PUM2 PUM1	3.59e-05	2	209	2	26517885
Pubmed	Involvement of HIV-1 protease in virus-induced cell killing.	PARP1 PARP4	3.59e-05	2	209	2	15781132
Pubmed	Interaction between fatty acid synthase and human epidermal growth receptor 2 (HER2) in osteosarcoma cells.	ERBB2 FASN	3.59e-05	2	209	2	25674245
Pubmed	Structure of the HECT C-lobe of the UBR5 E3 ubiquitin ligase.	UBE2D2 UBR5	3.59e-05	2	209	2	23027739
Pubmed	Principles of mRNA control by human PUM proteins elucidated from multimodal experiments and integrative data analysis.	PUM2 PUM1	3.59e-05	2	209	2	32753408
Pubmed	Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.	ERBB2 FASN	3.59e-05	2	209	2	15235125
Pubmed	Effects of PUMILIO1 and PUMILIO2 knockdown on cardiomyogenic differentiation of human embryonic stem cells culture.	PUM2 PUM1	3.59e-05	2	209	2	32437472
Pubmed	High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.	DKC1 TERT	3.59e-05	2	209	2	22664374
Pubmed	Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes.	ERBB2 FASN	3.59e-05	2	209	2	18528705
Pubmed	Clinical, electrophysiologic, and genetic study of non-dystrophic myotonia in French-Canadians.	CLCN1 G6PC3	3.59e-05	2	209	2	18337100
Pubmed	Endogenous TLR2 ligand embedded in the catalytic region of human cysteinyl-tRNA synthetase 1.	CARS1 TLR2	3.59e-05	2	209	2	32461342
Pubmed	GSE4, a Small Dyskerin- and GSE24.2-Related Peptide, Induces Telomerase Activity, Cell Proliferation and Reduces DNA Damage, Oxidative Stress and Cell Senescence in Dyskerin Mutant Cells.	DKC1 TERT	3.59e-05	2	209	2	26571381
Pubmed	Expression status of fatty acid synthase (FAS) but not HER2 is correlated with the differentiation grade and prognosis of esophageal carcinoma.	ERBB2 FASN	3.59e-05	2	209	2	23419663
Pubmed	Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization.	ERBB2 SMYD3	3.59e-05	2	209	2	28639750
Pubmed	DPP3 promotes breast cancer tumorigenesis by stabilizing FASN and promoting lipid synthesis.	FASN DPP3	3.59e-05	2	209	2	38655619
Pubmed	The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita.	DKC1 TERT	3.59e-05	2	209	2	22058290
Pubmed	Alternate modes of cognate RNA recognition by human PUMILIO proteins.	PUM2 PUM1	3.59e-05	2	209	2	21397187
Pubmed	LRP1 Regulates Retinal Angiogenesis by Inhibiting PARP-1 Activity and Endothelial Cell Proliferation.	PARP1 LRP1	3.59e-05	2	209	2	26634655
Pubmed	Poly (ADP-ribose) polymerase inhibition enhances trastuzumab antitumour activity in HER2 overexpressing breast cancer.	ERBB2 PARP1	3.59e-05	2	209	2	25128455
Pubmed	PUMILIO proteins promote colorectal cancer growth via suppressing p21.	PUM2 PUM1	3.59e-05	2	209	2	35338151
Pubmed	Solubility-based genetic screen identifies RING finger protein 126 as an E3 ligase for activation-induced cytidine deaminase.	UBE2D2 UBE2D3 ZMIZ2 RNF126	3.99e-05	32	209	4	23277564
Pubmed	Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation.	LGALS9C LGALS9B TLR2	4.52e-05	12	209	3	23817958
Pubmed	Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.	NLRP7 NXPE4 NKX2-3 IRF5 ARHGAP30 IL1RL2 PLTP SLAMF1 SBNO2 CXCR1	4.65e-05	342	209	10	23128233
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ERBB2 AGO2 VPS13C ADGRB3 AGO4 PLPPR4 INTS2 NBEAL2 XPO4 SLIT3 LHFPL2 KDM4B	9.53e-05	529	209	12	14621295
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	CNKSR1 RELN PDE2A ATRX ADGRB3 ZMYM2 NELL1 PARP1 UBA7 OSBPL1A MAP3K10 SMPD3 SMYD3 ANK2 EFEMP2 MAGI3 INTS8 PDLIM5 FBH1 LRP1	1.06e-04	1285	209	20	35914814
Pubmed	MYCN amplification, TERT rearrangements and ATRX mutations in neuroblastoma: clinicopathological correlates- an Indian perspective.	ATRX TERT	1.07e-04	3	209	2	37460674
Pubmed	Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita.	DKC1 TERT	1.07e-04	3	209	2	33003434
Pubmed	Galectin-9 regulates follicular helper T cells to inhibit humoral autoimmunity-induced pulmonary fibrosis.	LGALS9C LGALS9B	1.07e-04	3	209	2	33316546
Pubmed	Transcriptional activation of hTERT in breast carcinomas by the Her2-ER81-related pathway.	ERBB2 TERT	1.07e-04	3	209	2	19718948
Pubmed	Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.	LGALS9C LGALS9B	1.07e-04	3	209	2	28704475
Pubmed	Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.	LGALS9C LGALS9B	1.07e-04	3	209	2	23836896
Pubmed	Protein composition of catalytically active human telomerase from immortal cells.	DKC1 TERT	1.07e-04	3	209	2	17395830
Pubmed	Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes.	LGALS9C LGALS9B	1.07e-04	3	209	2	7890611
Pubmed	Galectin-9 Is a Novel Regulator of Epithelial Restitution.	LGALS9C LGALS9B	1.07e-04	3	209	2	32380082
Pubmed	Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.	LGALS9C LGALS9B	1.07e-04	3	209	2	23667648
Pubmed	Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.	ATRX TERT	1.07e-04	3	209	2	31960234
Pubmed	Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.	LGALS9C LGALS9B	1.07e-04	3	209	2	28877989
Pubmed	Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.	LGALS9C LGALS9B	1.07e-04	3	209	2	19800850
Pubmed	A novel function of human Pumilio proteins in cytoplasmic sensing of viral infection.	PUM2 PUM1	1.07e-04	3	209	2	25340845
Pubmed	RING finger E3 ligase PPP1R11 regulates TLR2 signaling and innate immunity.	UBE2D2 TLR2	1.07e-04	3	209	2	27805901
Pubmed	Increased biglycan in aortic valve stenosis leads to the overexpression of phospholipid transfer protein via Toll-like receptor 2.	PLTP TLR2	1.07e-04	3	209	2	20382708
Pubmed	UBR5 Is Coamplified with MYC in Breast Tumors and Encodes an Ubiquitin Ligase That Limits MYC-Dependent Apoptosis.	UBE2D3 UBR5	1.07e-04	3	209	2	32029551
Pubmed	The functional cobalamin (vitamin B12)-intrinsic factor receptor is a novel complex of cubilin and amnionless.	AMN1 CUBN	1.07e-04	3	209	2	14576052
Pubmed	Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins.	PUM2 PUM1	1.07e-04	3	209	2	26724866
Pubmed	Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism.	F2 LRP1	1.07e-04	3	209	2	17155964
Pubmed	Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.	LGALS9C LGALS9B	1.07e-04	3	209	2	37105392
Pubmed	Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson's disease.	LGALS9C LGALS9B	1.07e-04	3	209	2	36479526
Pubmed	Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy.	LGALS9C LGALS9B	1.07e-04	3	209	2	23242525
Pubmed	Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice.	LGALS9C LGALS9B	1.07e-04	3	209	2	19851072
Pubmed	The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.	LGALS9C LGALS9B	1.07e-04	3	209	2	33923930
Pubmed	Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.	OBSCN ANK2	1.07e-04	3	209	2	18782775
Pubmed	Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases.	LGALS9C LGALS9B	1.07e-04	3	209	2	31969388
Pubmed	The Epac-Phospholipase Cε Pathway Regulates Endocannabinoid Signaling and Cocaine-Induced Disinhibition of Ventral Tegmental Area Dopamine Neurons.	RAPGEF3 PLCE1	1.07e-04	3	209	2	28209735
Cytoband	3p21.1	CHDH ASB14 DNAH1 CACNA2D3	4.08e-05	42	209	4	3p21.1
Cytoband	13q11-q12	ZMYM2 LATS2	1.23e-04	4	209	2	13q11-q12
Cytoband	11p11	F2 ACCS	2.04e-04	5	209	2	11p11
GeneFamily	Zinc fingers\|Zinc fingers PARP-type\|Poly(ADP-ribose) polymerases	PARP6 PARP1 PARP4 PARP8	6.76e-06	17	136	4	684
GeneFamily	Argonaute/PIWI family	AGO2 AGO4 PIWIL2	2.27e-05	8	136	3	408
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCL2 PLA2G4E PLCE1	3.69e-04	19	136	3	832
GeneFamily	Phospholipid phosphatase related	PLPPR3 PLPPR4	5.53e-04	5	136	2	1127
GeneFamily	CD molecules\|C-X-C motif chemokine receptors	CXCR3 CXCR1	8.26e-04	6	136	2	1094
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND4B DENND5B FLCN	8.48e-04	25	136	3	504
GeneFamily	WD repeat domain containing\|BEACH domain containing	LYST NBEAL2	1.95e-03	9	136	2	1230
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CCDC30 ZMYM2 CPED1 NELL1 UBR5 XRN1 MAGI3 LHFPL2 SPIDR	2.75e-07	188	209	9	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CCDC30 ZMYM2 CPED1 NELL1 UBR5 XRN1 MAGI3 LHFPL2 SPIDR	2.75e-07	188	209	9	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CCDC30 ZMYM2 CPED1 NELL1 UBR5 XRN1 MAGI3 LHFPL2 SPIDR	2.75e-07	188	209	9	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA3 SEMA3A RAPGEF3 RXFP2 KLK5 EPHX4 SLIT3 PLCE1	7.63e-07	156	209	8	abf9dd075b1ca8f613c660cc82f8a5af071fb6ab
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ITGA3 SEMA3A RAPGEF3 RXFP2 KLK5 EPHX4 SLIT3 PLCE1	7.63e-07	156	209	8	dd41ed918b07fa248da458a629b3c53cb7ea8764
ToppCell	ILEUM-inflamed-(9)_Neuro_cell\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RELN ADGRB3 KCTD1 ANK2 PCDHB2 ABCA6 DCHS1 ASB4	2.06e-06	178	209	8	611504b0a9e6318b18fba83787b03f9245c82252
ToppCell	ILEUM-inflamed-(9)_Enteric_neurons\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RELN ADGRB3 KCTD1 ANK2 PCDHB2 ABCA6 DCHS1 ASB4	2.06e-06	178	209	8	d9142151819afb0dc22bfb32a9c9dba5f553067d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KCTD1 NELL1 ADAMTS17 ANK2 CPT1A SLC22A2 CGNL1 CACNA2D3	2.06e-06	178	209	8	dfed0fbf7a73b8a9e00178ec58dc4592b271c344
ToppCell	normal_Lung-Myeloid_cells-pDCs\|normal_Lung / Location, Cell class and cell subclass	CPED1 PARP6 MYO15B SMPD3 CXCR3 XPO4 CPT1A RSKR	2.97e-06	187	209	8	d36751372fd40a46441f07735c9c3c5dcb503f24
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 LYST SEMA3A ZNF462 SMPD3 DNAH1 SLC22A2 CGNL1	3.21e-06	189	209	8	8e583ec4df0f5b79ce5211cc99ecd8616d180bde
ToppCell	10x5'v1-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LGALS9C LGALS9B TKTL1 SLFN5 CXCR3 TRGV9 ZAP70 P2RY11	3.34e-06	190	209	8	251d50a77e5118a9ad19ea01a7c7c862230ed63c
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN SEMA3A STAB2 ANK2 MROH2A POSTN CACNA2D3 PLCE1	3.34e-06	190	209	8	f50b9814a1beac67dc042a8c27dfd085ceeda3a6
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN SEMA3A STAB2 ANK2 MROH2A POSTN CACNA2D3 PLCE1	3.34e-06	190	209	8	a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c
ToppCell	droplet-Lung-21m-Endothelial-lymphatic_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN SEMA3A STAB2 ANK2 MROH2A POSTN CACNA2D3 PLCE1	3.34e-06	190	209	8	57c136bf6d7feafb4a220877bed0cc8fdf314db2
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADGRB3 NELL1 ANK2 EFEMP2 NTNG1 ABCA6 SLIT3 LRP1	3.61e-06	192	209	8	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	10x5'v1-week_17-19-Lymphocytic_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LGALS9C LGALS9B TKTL1 SLFN5 CXCR3 TRGV9 ZAP70 P2RY11	3.61e-06	192	209	8	63e815664b228575886396387d2738cd73855759
ToppCell	10x5'v1-week_17-19-Lymphocytic_NK-T_NK\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LGALS9C LGALS9B TKTL1 SLFN5 CXCR3 TRGV9 ZAP70 P2RY11	3.61e-06	192	209	8	095151a4f878944835945f698aa0e3b540ffc8c3
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADGRB3 CPED1 NELL1 ANK2 NTNG1 ABCA6 SLIT3 LRP1	3.75e-06	193	209	8	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADGRB3 NELL1 ADAMTS17 ANK2 NTNG1 ABCA6 SLIT3 LRP1	3.89e-06	194	209	8	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RELN ITGA3 ADORA1 RAPGEF3 KLK5 PLTP NTNG1 PLCE1	3.89e-06	194	209	8	43eb677a76634bb9a48a40e0d607c4936ae64bcc
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RELN ITGA3 RAPGEF3 KLK5 NTNG1 NLRP1 SLIT3 PLCE1	3.89e-06	194	209	8	1374600957c7d7f0b05fd2c1186f521b9096d4ef
ToppCell	COVID-19\|World / Condition, Lineage and Cell class	SLFN5 PARP1 PLTP CXCR3 SLAMF1 ZAP70 TLR2 LHFPL2	4.36e-06	197	209	8	228f641d79282cc3dc51b95a1f4b0cccfc200735
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NKX2-3 CPED1 SEMA3A NELL1 EFEMP2 POSTN SLIT3 LRP1	4.53e-06	198	209	8	75d104eead681f6bf47c4dd24913cc768c9a1717
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CPED1 NELL1 ANK2 EFEMP2 NTNG1 ABCA6 SLIT3 LRP1	4.70e-06	199	209	8	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	PLPPR3 NELL1 PLPPR4 EFEMP2 NTNG1 ABCA6 SLIT3 LRP1	4.87e-06	200	209	8	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Sepsis-Leuk-UTI-Lymphocyte-T/NK-NK\|Leuk-UTI / Disease, condition lineage and cell class	LGALS9C ERBB2 LGALS9B TKTL1 TLE5 TRGV9 ZAP70 CXCR1	4.87e-06	200	209	8	bb37fed4872e71f413ae7c4aa12586fa31075334
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	PLPPR3 NELL1 PLPPR4 EFEMP2 NTNG1 ABCA6 SLIT3 LRP1	4.87e-06	200	209	8	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	CPED1 NELL1 PLPPR4 ANK2 NTNG1 ABCA6 SLIT3 LRP1	4.87e-06	200	209	8	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	P28-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RELN PDE2A SEMA3A CXCR3 STAB2 MROH2A PLCE1	2.07e-05	177	209	7	e96a7e4544710aaab8bd2800ecff9667880a8bf4
ToppCell	P28-Endothelial-lymphatic_endothelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RELN PDE2A SEMA3A CXCR3 STAB2 MROH2A PLCE1	2.07e-05	177	209	7	6e330aa3c87fd640526b746a9deb3b2250d2518c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KCTD1 NELL1 ADAMTS17 ANK2 SLC22A2 CGNL1 CACNA2D3	2.23e-05	179	209	7	2e49b215b71438400aebb483f2c2c08d5e956961
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KCTD1 NELL1 ADAMTS17 ANK2 SLC22A2 CGNL1 CACNA2D3	2.23e-05	179	209	7	d0fa700648db8ce76a8aa689879a25048299fa40
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPED1 NELL1 ADAMTS17 NTNG1 ABCA6 SLIT3 LRP1	2.31e-05	180	209	7	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN NELL1 ASB9 PCDH19 PDLIM5 SLC22A2 PLCE1	2.31e-05	180	209	7	c6030e725e3d86d5d74a1676330c77ffeceb324f
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	VPS13C PARP1 UBA7 HIBCH CXCR3 XPO4 ZAP70	2.39e-05	181	209	7	986c036e656f24fe374807e2711cec9e3c83c892
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACRBP CHDH KIF24 USP20 UBA7 AGO4 UBR5	2.39e-05	181	209	7	e2d03115a87f45a7ddd3ade6b9ac3843639bd41a
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACRBP CHDH KIF24 USP20 UBA7 AGO4 UBR5	2.39e-05	181	209	7	d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264
ToppCell	droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A SLFN5 SEMA3A RAPGEF3 PCDH19 PLTP CH25H	2.48e-05	182	209	7	ab5761bf9af439231cd0f487b6467e372672a517
ToppCell	droplet-Pancreas-Exocrine-18m-Endothelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A SLFN5 SEMA3A RAPGEF3 PCDH19 PLTP CH25H	2.48e-05	182	209	7	3b4dbf61ca0fe50efe05449815630e301cb76630
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN OBSCN USH2A STAB2 MROH2A DNAH1 PLCE1	2.66e-05	184	209	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN OBSCN USH2A STAB2 MROH2A DNAH1 PLCE1	2.66e-05	184	209	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN OBSCN USH2A STAB2 MROH2A DNAH1 PLCE1	2.66e-05	184	209	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SEMA3A STAB2 ANK2 MROH2A POSTN PLCE1	2.75e-05	185	209	7	3a4ae836e882e8d29eb0a2dfab5677f10f2d365f
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC30 KCTD1 RREB1 CFAP65 CFAP54 NPY2R DNAH1	2.75e-05	185	209	7	05bc89a566b0db90ae06506e067190a4739a0974
ToppCell	droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN SEMA3A STAB2 ANK2 MROH2A POSTN PLCE1	2.75e-05	185	209	7	224f0b022c21dd40bf1f7503f00b3107ef958975
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRX VPS13C IRF5 SLFN5 LYST PARP1 XRN1	2.75e-05	185	209	7	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TKTL1 SLFN5 CXCR3 TRGV9 SLAMF1 ZAP70 P2RY11	2.85e-05	186	209	7	e0eeef2b9e06324354c5a11a4c6d4c98546f32af
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RELN NELL1 RXFP2 NTNG1 POSTN SLIT3 CGNL1	2.85e-05	186	209	7	8915436d09775f2828a7678af203b1082b36e21c
ToppCell	droplet-Lung-LUNG-1m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN KCTD1 SEMA3A SMPD3 ANK2 MROH2A PLCE1	2.95e-05	187	209	7	9c9ae8725905ba0cfe407878006ed06c2480fb72
ToppCell	normal_Lung-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	PARP6 MYO15B SMPD3 CXCR3 XPO4 CPT1A RSKR	2.95e-05	187	209	7	a3592f056e1c2f82ba325fea2ecc4dd6c6347c81
ToppCell	droplet-Lung-LUNG-1m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN KCTD1 SEMA3A SMPD3 ANK2 MROH2A PLCE1	2.95e-05	187	209	7	9e9460e57cdc9cd0a0de2866b140e06d0bc19a8f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KCTD1 NELL1 ADAMTS17 ANK2 SLC22A2 CGNL1 CACNA2D3	2.95e-05	187	209	7	85e58a312fc325e4063a2d250666b99b8f99beb6
ToppCell	10x5'v1-week_17-19-Lymphocytic_T-T_NK-NK_T_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SLFN5 ZNF462 FCGBP ADAMTS17 PARP8 SLAMF1 ZAP70	2.95e-05	187	209	7	3301e0fca8c436d136c71f1a8fd59b3bb11bdd83
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	ITGA3 NBEAL2 LNX2 MAGI3 CGNL1 CACNA2D3 PLCE1	2.95e-05	187	209	7	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN KCTD1 SEMA3A SMPD3 ANK2 MROH2A PLCE1	3.05e-05	188	209	7	dc52dd2957be3f40001f0a56f3d9ac9d66ea466e
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic\|GI_large-bowel / Manually curated celltypes from each tissue	FCGBP ASB9 TREML1 PLTP TLR2 TREM2 LRP1	3.05e-05	188	209	7	d0045fdda757d191dabc7853f6a6e99c0e97d93d
ToppCell	wk_08-11-Hematologic_Lymphocytic-NK-Intermediate_NK\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	LGALS9C LGALS9B ARHGAP30 TKTL1 CXCR3 TRGV9 ZAP70	3.05e-05	188	209	7	a8170e4ce6406af9f5ad5317e6e26efa7bc66411
ToppCell	10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes\|GI_large-bowel / Manually curated celltypes from each tissue	FCGBP ASB9 TREML1 PLTP TLR2 TREM2 LRP1	3.05e-05	188	209	7	0bcf04aa47738f43c1a87dae5dc487738ee86f8c
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN KCTD1 SEMA3A SMPD3 ANK2 MROH2A PLCE1	3.05e-05	188	209	7	2ef08313087e91985bcffc46c3798470cdeec49c
ToppCell	droplet-Lung-1m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RELN KCTD1 SEMA3A SMPD3 ANK2 MROH2A PLCE1	3.05e-05	188	209	7	1f1604b6dc0a8ad0be3d9aac0bef448459c22465
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NELL1 ANK2 EFEMP2 NTNG1 ABCA6 SLIT3 LRP1	3.16e-05	189	209	7	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KCTD1 ITGA3 NELL1 NBEAL2 ADAMTS17 ABCA6 CACNA2D3	3.16e-05	189	209	7	e32172ad09e93f6ac6ea2b92145b2b73003f7970
ToppCell	droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPED1 LYST SEMA3A ZNF462 DNAH1 SLC22A2 CGNL1	3.16e-05	189	209	7	fb2253b8463d08b3d28e952a31a23dea2c2d986b
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RELN PDE2A P4HA3 SEMA3A STAB2 ANK2 ABCA6	3.27e-05	190	209	7	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	NLRP7 NXPE4 DENND5B TERT SLAMF1 CBY2 FCRL5	3.38e-05	191	209	7	da4062a0f6d0af6d330acf11da216c64b0fa7c73
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADGRB3 NELL1 ANK2 NTNG1 ABCA6 SLIT3 LRP1	3.38e-05	191	209	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN PDE2A SEMA3A STAB2 ANK2 CACNA2D3 PLCE1	3.38e-05	191	209	7	48823a97c38263f2c6e58348214f5b62773a6368
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN PDE2A SEMA3A STAB2 ANK2 CACNA2D3 PLCE1	3.38e-05	191	209	7	0eedc66e967b1837ce2c14f8c14b3c1eba868c76
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPED1 NELL1 ANK2 NTNG1 ABCA6 SLIT3 LRP1	3.49e-05	192	209	7	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NELL1 ADAMTS17 ANK2 EFEMP2 ABCA6 SLIT3 LRP1	3.49e-05	192	209	7	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NELL1 ANK2 EFEMP2 NTNG1 ABCA6 SLIT3 LRP1	3.49e-05	192	209	7	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPED1 NELL1 ADAMTS17 ANK2 EFEMP2 SLIT3 LRP1	3.49e-05	192	209	7	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	background-NK_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	ARHGAP30 SLFN5 PLCL2 PARP8 TRGV9 ZAP70 P2RY11	3.61e-05	193	209	7	f8d6eff1e04926f85d265ec39fe66897fe29574d
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-NK_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGAP30 SLFN5 CXCR3 PARP8 TRGV9 ZAP70 P2RY11	3.61e-05	193	209	7	044fba87c4d10f4943a9f57315920280a4d097e7
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK-CD56_bright_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LGALS9C LGALS9B TKTL1 SLFN5 CXCR3 PARP8 ZAP70	3.61e-05	193	209	7	46f94a1062b098205e8ce3ed380c0202a4d97678
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPED1 NELL1 ANK2 EFEMP2 ABCA6 SLIT3 LRP1	3.73e-05	194	209	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LGALS9C LGALS9B TKTL1 SLFN5 CXCR3 PARP8 ZAP70	3.73e-05	194	209	7	5a859885c0f9b8554b0d203e371c70928ad4418f
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-Activated_T\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGAP30 SLFN5 CXCR3 PARP8 TRGV9 SLAMF1 ZAP70	3.73e-05	194	209	7	e3705346755cbf65fc276d4d4fbee936ed6bb7bf
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SLFN5 GCSAM KLK5 CXCR3 PARP8 SLAMF1 ZAP70	3.73e-05	194	209	7	c49f3341a19128855f084bcf18ef3da4bab79099
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADGRB3 NELL1 ANK2 NTNG1 ABCA6 SLIT3 LRP1	3.73e-05	194	209	7	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	10x5'v1-week_14-16-Lymphocytic_NK-T_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	LGALS9C LGALS9B TKTL1 SLFN5 CXCR3 PARP8 ZAP70	3.73e-05	194	209	7	7d35ac70ba966eb1fee4197f7de6d6116326a442
ToppCell	Leuk-UTI-Lymphocyte-T_NK-NK\|Leuk-UTI / Disease, Lineage and Cell Type	LGALS9C ERBB2 LGALS9B TKTL1 TRGV9 ZAP70 CXCR1	3.73e-05	194	209	7	36afc4e48d267be3b8aa1e33fad043bcd54c6bc5
ToppCell	Monocytes-M2-like_CD16+_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	CPED1 OSBPL1A PLTP CH25H TLR2 TREM2 LRP1	3.85e-05	195	209	7	10fa47bdcf6c9784ea930b75a5861e139421feed
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RELN ITGA3 KLK5 PLTP NTNG1 SLIT3 PLCE1	3.98e-05	196	209	7	545d2e4469924d333e3f655f559c899fa1260196
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ADGRB3 SEMA3A NTNG1 POSTN ABCA6 SLIT3 LRP1	4.11e-05	197	209	7	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	mild-Plasmablast\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CNKSR1 PRSS16 TMEM214 HIBCH DENND5B TERT FCRL5	4.24e-05	198	209	7	b14b9e67815f93fac7bd8e5e6f1aa100951b4ac1
ToppCell	Healthy-NK\|World / disease group, cell group and cell class	ERBB2 LGALS9B TKTL1 SLFN5 TLE5 ZAP70 CXCR1	4.24e-05	198	209	7	517e49669e13e428aa66081a0ce83c30f3b9b08b
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RELN ITGA3 RAPGEF3 KLK5 PLTP SLIT3 PLCE1	4.38e-05	199	209	7	b9338b739162cd8e5661c9a4dcb41a31219b5723
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ADAMTS17 ANK2 EFEMP2 NTNG1 ABCA6 SLIT3 LRP1	4.38e-05	199	209	7	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RELN ITGA3 RAPGEF3 KLK5 PLTP SLIT3 PLCE1	4.38e-05	199	209	7	c972d3036151403f26fa9d6271520639c281ab84
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	NELL1 ANK2 EFEMP2 NTNG1 ABCA6 SLIT3 LRP1	4.52e-05	200	209	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADGRB3 CPED1 ANK2 NTNG1 ABCA6 SLIT3 LRP1	4.52e-05	200	209	7	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Biopsy_Other_PF-Immune-NK_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	LGALS9C LGALS9B TKTL1 PARP8 TRGV9 ZAP70 CXCR1	4.52e-05	200	209	7	418d665b8431697fc9e516258c9fe374257750d9
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADGRB3 CPED1 ANK2 NTNG1 ABCA6 SLIT3 LRP1	4.52e-05	200	209	7	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_submucosal-gland-SMG_Serous\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PRSS16 IL1RL2 LRIG2 ADORA1 FCGBP DENND4B SMYD3	4.52e-05	200	209	7	61bae10c8b12196d9cee766897971b81cb897191
ToppCell	(61)_LYVE1_Macrophage\|World / shred on Cell_type and subtype	NELL1 OSBPL1A PLTP ABCA6 TLR2 TREM2 LRP1	5.45e-05	206	209	7	711e961a9a03bfd2f0958bd14f25f7f207a2f2b5
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PGAP3 TKTL1 F2 MROH2A ABCA6 SUSD2	6.60e-05	146	209	6	86cddd0e7f954547b7ffdccb0329cd5c4b725ac1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ACRBP RAPGEF3 KLK5 STAB2 SLIT3 PLCE1	7.39e-05	149	209	6	cc6224c6b79f43b97adc1ce48ca4906bff2ad318
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CNKSR1 SDE2 NELL1 VWA5B1 C15orf61 MMD	7.39e-05	149	209	6	61d84838a841ed2d6b8c5f86d423a4e6b3dcc9cb
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ACRBP RAPGEF3 KLK5 STAB2 SLIT3 PLCE1	7.39e-05	149	209	6	24a7538b54b2a5291503c7493fefed4e45e8d710
Disease	symmetrical dimethylarginine measurement	NELL1 PLCL2 SMYD3	2.54e-05	9	201	3	EFO_0006523
Disease	Mitochondrial DNA Deletion Syndromes	SUCLG1 FBXL4 DGUOK	2.54e-05	9	201	3	cv:CN043632
Disease	Colorectal Carcinoma	ETFDH OBSCN ADORA1 NELL1 PARP1 ANK2 PARP8 NTNG1 CUBN POSTN ABCA6 TLR2 DCHS1 LRP1 FLCN EDRF1	2.79e-05	702	201	16	C0009402
Disease	Cryptorchidism	ATRX RXFP2 PUM1	3.61e-05	10	201	3	C0010417
Disease	level of triggering receptor expressed on myeloid cells 2 in blood serum	TREML1 TREM2	4.62e-05	2	201	2	OBA_2043927
Disease	Malignant neoplasm of breast	ERBB2 PDE2A OBSCN SEMA3A PARP1 FASN CLCN1 ACCS TREML1 PGBD3 ANK2 CUBN CPT1A TERT SLAMF1 ARAF NCOA1 PACC1 FCRL5 DOP1A	4.94e-05	1074	201	20	C0006142
Disease	pulse pressure measurement	CWF19L2 DDAH1 CCDC30 ETFDH IRF5 RREB1 FASN RXFP2 MTCH2 CEP97 ANK2 INTS8 RNF126 PDLIM5 LATS2 SLC22A2 SLIT3 LRP1 LHFPL2 KDM4B RSKR PLCE1	2.22e-04	1392	201	22	EFO_0005763
Disease	Mitochondrial DNA depletion syndrome, encephalomyopathic form	SUCLG1 FBXL4	2.75e-04	4	201	2	cv:C4707428
Disease	cognitive decline measurement, disease progression measurement	PARP6 UBR5	2.75e-04	4	201	2	EFO_0007710, EFO_0008336
Disease	periostin measurement	STAB2 POSTN	2.75e-04	4	201	2	EFO_0020628
Disease	kidney failure (biomarker_via_orthology)	PARP1 SLC22A2 TLR2	2.78e-04	19	201	3	DOID:1074 (biomarker_via_orthology)
Disease	corpus callosum posterior volume measurement	SEMA3A CFAP54 ATP13A2 LHFPL2	4.38e-04	52	201	4	EFO_0010298
Disease	gallbladder carcinoma (is_implicated_in)	UBR5 TERT	4.56e-04	5	201	2	DOID:4948 (is_implicated_in)
Disease	Obesity	ETFDH F2 PARP1 FASN RAPGEF3 MTCH2 SLC22A2	5.36e-04	205	201	7	C0028754
Disease	IGF-1 measurement	VPS13C RREB1 ADCY1 ZNF462 ZMIZ2 DENND5B STAB2 SLC22A2 SLIT3 CDC5L KDM4B	5.57e-04	488	201	11	EFO_0004627
Disease	corpus callosum volume measurement	SEMA3A POLR1F NELL1 MTCH2 ATP13A2	6.22e-04	100	201	5	EFO_0010299
Disease	cortical thickness	PDS5B RELN DDAH1 RREB1 CPED1 SEMA3A ZNF462 POLR1F NELL1 MTCH2 ATP13A2 CBY2 LRP1 ATOH1 CDC5L KDM4B CACNA2D3 PLCE1	6.46e-04	1113	201	18	EFO_0004840
Disease	urinary tract infection (is_implicated_in)	TLR2 CXCR1	6.80e-04	6	201	2	DOID:0080784 (is_implicated_in)
Disease	Agouti-related protein measurement	SMPD3 ABCA6 CDH16	8.07e-04	27	201	3	EFO_0008016
Disease	X-Linked Dyskeratosis Congenita	DKC1 TERT	9.48e-04	7	201	2	C1148551
Disease	colorectal cancer	ADGRB3 NKX2-3 RREB1 RXFP2 DENND5B CUBN TERT ZAP70 SBNO2 LRP1 ATOH1 PUM1	9.52e-04	604	201	12	MONDO_0005575
Disease	Hematopoetic Myelodysplasia	ATRX SMPD3 TLR2	9.99e-04	29	201	3	C2713368
Disease	Parkinsonian Disorders	LYST PARP1 ATP13A2	1.10e-03	30	201	3	C0242422
Disease	cardiomyopathy (implicated_via_orthology)	ERBB2 ARAF PDLIM5 LRP1	1.42e-03	71	201	4	DOID:0050700 (implicated_via_orthology)
Disease	chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	RXFP2 PLTP SLC22A2	1.59e-03	34	201	3	EFO_0008317, EFO_0008596, EFO_0020947
Disease	underweight body mass index status	ADGRB3 ANK2	1.61e-03	9	201	2	EFO_0005936
Disease	Disorder of fatty acid metabolism	ETFDH CPT1A	1.61e-03	9	201	2	cv:C0268634
Disease	Dyskeratosis congenita	DKC1 TERT	1.61e-03	9	201	2	cv:C0265965
Disease	hepatitis C (is_marker_for)	IRF5 F2 TERT	1.74e-03	35	201	3	DOID:1883 (is_marker_for)
Disease	HOYERAAL-HREIDARSSON SYNDROME	DKC1 TERT	2.00e-03	10	201	2	C1846142
Disease	alpha wave measurement, electroencephalogram measurement	DNAH1 TFB1M	2.00e-03	10	201	2	EFO_0004357, EFO_0006870
Disease	osteoarthritis, hand	F2 CFAP54 CDC5L	2.04e-03	37	201	3	EFO_1000789
Disease	nitric oxide exhalation measurement	SMYD3 ANK2 CACNA2D3	2.20e-03	38	201	3	EFO_0005536
Disease	rheumatoid arthritis, Crohn's disease	NKX2-3 LRIG2 MAGI3	2.20e-03	38	201	3	EFO_0000384, EFO_0000685
Disease	dilated cardiomyopathy (implicated_via_orthology)	ERBB2 MTCH2 CXCR3 PDLIM5	2.21e-03	80	201	4	DOID:12930 (implicated_via_orthology)
Disease	peak expiratory flow	RREB1 UBA7 XRN1 ADAMTS17 MTCH2 ASB14 ATP13A2 LRP1 NCOA1 CACNA2D3	2.32e-03	498	201	10	EFO_0009718
Disease	corpus callosum anterior volume measurement	SEMA3A POLR1F CBY2	2.38e-03	39	201	3	EFO_0010295
Disease	liver cirrhosis (is_marker_for)	RELN IRF5 F2 PARP1	2.42e-03	82	201	4	DOID:5082 (is_marker_for)
Disease	gastric adenocarcinoma (is_implicated_in)	UBR5 PLCE1	2.44e-03	11	201	2	DOID:3717 (is_implicated_in)
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	SLIT3 LRP1	2.91e-03	12	201	2	DOID:3827 (implicated_via_orthology)
Disease	Myeloproliferative disease	ZMYM2 TERT	2.91e-03	12	201	2	C0027022
Disease	Schizophrenia	RELN PRSS16 F2 CFAP65 SEMA3A ADORA1 PLCL2 NTNG1 PDLIM5 SBNO2 TLR2 SLIT3 LRP1 CGNL1	3.06e-03	883	201	14	C0036341
Disease	Childhood Medulloblastoma	ERBB2 ATOH1 KDM4B	3.14e-03	43	201	3	C0278510
Disease	Melanotic medulloblastoma	ERBB2 ATOH1 KDM4B	3.14e-03	43	201	3	C1275668
Disease	Medullomyoblastoma	ERBB2 ATOH1 KDM4B	3.14e-03	43	201	3	C0205833
Disease	Desmoplastic Medulloblastoma	ERBB2 ATOH1 KDM4B	3.14e-03	43	201	3	C0751291
Disease	Adult Medulloblastoma	ERBB2 ATOH1 KDM4B	3.14e-03	43	201	3	C0278876
Disease	high grade glioma (implicated_via_orthology)	F2 CXCR3 ARAF	3.36e-03	44	201	3	DOID:3070 (implicated_via_orthology)
Disease	lung disease (implicated_via_orthology)	ADORA1 TLR2	3.43e-03	13	201	2	DOID:850 (implicated_via_orthology)
Disease	Prostatic Neoplasms	ERBB2 ACRBP TBC1D2 PARP1 KLK5 STAB2 RNF31 EFEMP2 TERT NCOA1 ALOXE3	3.50e-03	616	201	11	C0033578
Disease	Malignant neoplasm of prostate	ERBB2 ACRBP TBC1D2 PARP1 KLK5 STAB2 RNF31 EFEMP2 TERT NCOA1 ALOXE3	3.50e-03	616	201	11	C0376358
Disease	homocysteine measurement	POLR1F CUBN MMACHC	3.81e-03	46	201	3	EFO_0004578
Disease	pulmonary emphysema (is_marker_for)	SMPD3 CXCR3	3.98e-03	14	201	2	DOID:9675 (is_marker_for)
Disease	calcium measurement	ZMYM2 RREB1 TLE5 A4GALT MTCH2 CARS1 CPT1A ABCA6 SLC22A2 CGNL1 PLCE1	4.04e-03	628	201	11	EFO_0004838
Disease	Adenocarcinoma of large intestine	ERBB2 UBR5 ARAF FLCN	4.26e-03	96	201	4	C1319315
Disease	lung adenocarcinoma (is_implicated_in)	ERBB2 UBR5 TERT	4.56e-03	49	201	3	DOID:3910 (is_implicated_in)
Disease	Mitochondrial disease	SUCLG1 FBXL4 DGUOK	4.56e-03	49	201	3	cv:C0751651
Disease	Medulloblastoma	ERBB2 ATOH1 KDM4B	4.82e-03	50	201	3	C0025149
Disease	osteosarcoma (is_implicated_in)	EFEMP2 CDC5L	5.20e-03	16	201	2	DOID:3347 (is_implicated_in)
Disease	Dyskeratosis Congenita	DKC1 TERT	5.20e-03	16	201	2	C0265965
Disease	cholesterol in small VLDL measurement	PLTP ABCA6 SLC22A2	5.68e-03	53	201	3	EFO_0022228
Disease	Benign neoplasm of stomach	ERBB2 UBR5	5.87e-03	17	201	2	C0153943
Disease	allergic rhinitis (is_marker_for)	F2 TLR2	5.87e-03	17	201	2	DOID:4481 (is_marker_for)
Disease	Neoplasm of uncertain or unknown behavior of stomach	ERBB2 UBR5	5.87e-03	17	201	2	C0496905
Disease	Carcinoma in situ of stomach	ERBB2 UBR5	5.87e-03	17	201	2	C0154060
Disease	cervical artery dissection	LRP1 PLCE1	5.87e-03	17	201	2	EFO_1000059
Disease	perinatal necrotizing enterocolitis (biomarker_via_orthology)	PARP1 TLR2	5.87e-03	17	201	2	DOID:8677 (biomarker_via_orthology)
Disease	Acute Cerebrovascular Accidents	F2 CXCR3 ANK2	5.98e-03	54	201	3	C0751956
Disease	Major Depressive Disorder	RELN NELL1 TERT PDLIM5 SLIT3 LRP1	6.59e-03	243	201	6	C1269683
Disease	peptide measurement	NELL1 NLRP1 CNEP1R1 CACNA2D3	6.67e-03	109	201	4	EFO_0010520

Protein segments in the cluster

Peptide	Gene	Start	Entry
THCQYNFPQVGRTAL	CXCR3	201	P49682
VLQGLPREYVNARHC	ERBB2	546	P04626
TQCYGLLAPIIYHNI	CFAP54	1151	Q96N23
APIIGRTAAQCLEHY	CDC5L	86	Q99459
LTYCPQIRILLFHGC	AMN1	216	Q8IY45
HLGTPLYLACENQQR	ASB9	166	Q96DX5
YHVRGPINQVCSEIL	CPED1	1001	A4D0V7
GAITQHVCLYGNIRL	ACCS	196	Q96QU6
RHLGISLLSCFPNVQ	A4GALT	126	Q9NPC4
AILINIGPQTYFHTC	ADORA1	66	P30542
ELAHLANGTLNPYCV	ADGRB3	806	O60242
AAQPEICYQLLLNHG	ASB4	301	Q9Y574
HGCRNPTLVQLDQYE	ACRBP	66	Q8NEB7
LGYHLSLHRNEICNP	ABCA6	706	Q8N139
SVLGHLGYCPQENVL	ABCA6	1351	Q8N139
PHGNLIRLAVNELFC	C14orf28	181	Q4W4Y0
YILPTHIQAARAGNA	CPT1A	261	P50416
LHGFIYLQASPQVCL	DGUOK	186	Q16854
AHNAPSYRACVQLLS	DOP1A	2081	Q5JWR5
YTLINHRVLCTRPSG	GCSAM	86	Q8N6F7
SNKRSPLHLAIAYGC	ANKRD61	166	A6NGH8
LRHGANVNYFCRVNP	ASB14	406	A6NK59
HTYLPLEVCNIVAGQ	AGO4	326	Q9HCK5
QLQNGTHVATRPLYC	ADAMTS17	891	Q8TE56
HTYLPLEVCNIVAGQ	AGO2	336	Q9UKV8
YIQQACTRPITLHSA	CHDH	341	Q8NE62
RQVCQLPGLFSYAQH	MTCH2	46	Q9Y6C9
QCYLGRFNDIHVPIR	PDS5B	316	Q9NTI5
QQLTPYSQVHICLRS	INTS8	321	Q75QN2
QVFVLSTHPYGCRVI	PUM2	876	Q8TB72
NYCHTSQGDPIGLIL	PARP1	906	P09874
NAVGSCQKPYVALIH	HIBCH	126	Q6NVY1
VLCHLVPYAQGLAVQ	NPY2R	121	P49146
NIPHLQTRDTYEGLC	P4HA3	291	Q7Z4N8
VLLGIAQASCQPRHY	PCDHB2	21	Q9Y5E7
VHQAICNLNITLPIY	ANK2	1441	Q01484
YHQQTLPLGCRRSES	PCDH19	816	Q8TAB3
NRYLINHLLNSLPCV	NOL9	316	Q5SY16
QCDRYQLQLLAHDGP	DCHS1	2341	Q96JQ0
VALVAQLRFCGPNHI	OR11A1	161	Q9GZK7
RLHCSLTQYLNGPVP	PARP8	211	Q8N3A8
TCISLNRYLGIVHPF	P2RY11	121	Q96G91
ALQHPNIIALRGACL	MAP3K10	151	Q02779
PHYTLLITGLCRFQI	LONP2	96	Q86WA8
SRHNQNLGCYPVELE	MAGI3	1011	Q5TCQ9
EAYRCNFLGLSPHVQ	FLCN	411	Q8NFG4
QRCLAHSLVGTPNYI	LATS2	866	Q9NRM7
QPLCQYRAATIHHRL	EDRF1	1016	Q3B7T1
GPINHYRNIFSCLPL	EPHX4	276	Q8IUS5
RVFCLLAVAPGAHSQ	IGHV1-46	6	P01743
GTVLPSAQRFHINLC	LGALS9C	246	Q6DKI2
LAEAPTHCLNGRQQY	ALOXE3	331	Q9BYJ1
THCLNGRQQYVAAPL	ALOXE3	336	Q9BYJ1
QGPCSHLCLINYNRT	LRP1	1546	Q07954
RGPAVSLQHYCVNFS	CFAP65	461	Q6ZU64
RLAFGNHYQPQTLCI	KIAA1109	211	Q2LD37
GTVLPSAQRFHINLC	LGALS9B	246	Q3B8N2
LGIALHSPCYAQVRR	G6PC3	261	Q9BUM1
HSPCYAQVRRAQLGN	G6PC3	266	Q9BUM1
HNYARAVLSQPCNTL	LNX2	296	Q8N448
NQQICPVLYHAGTVL	PLTP	181	P55058
CEAQRGSLPILYQFH	FCRL5	401	Q96RD9
TLHCEVQRGSPQILY	FCRL5	491	Q96RD9
NRTGAVYLCPLTAHK	ITGA3	86	P26006
IRFPLNGYCHLNSVQ	KCTD1	191	Q719H9
GHSILCRSQQYPAAR	PDE2A	6	O00408
CLHYLAQALQAQPLG	NLRP1	551	Q9C000
VYLCLPNVRSLTEGH	CWF19L2	696	Q2TBE0
EGNANPTHRLLCYLL	FAM214B	471	Q7L5A3
YHLQTNKCLVAQGRP	GALNT11	486	Q8NCW6
ANITGFLPIHCIYQL	INTS2	546	Q9H0H0
PRHGQTNILVYITIC	NIPA2	171	Q8N8Q9
RSQLQLYLTCHGPTA	KIF24	1346	Q5T7B8
QVHASCYGIRPELVN	KDM4B	766	O94953
SRHVPQGAQAYTICG	RSKR	251	Q96LW2
RPLAGTIVYCAQHLT	LMLN2	276	A0A1B0GTW7
LGIYARCIRNPGVQH	LHFPL2	61	Q6ZUX7
AESVGLYLCLHPQVL	DPP3	511	Q9NY33
QAARQVHLCRGVFPL	PKLR	501	P30613
LRPNQLYCGAVLVHP	KLK5	86	Q9Y337
ISNPHGCRLFYSQLE	IRF5	266	Q13568
AHCNQVIRGPFLVAL	PDLIM5	421	Q96HC4
HGALQAILTFRLPYC	OR10G3	156	Q8NGC4
NDRLLVYGFIPHCTQ	PARP4	1081	Q9UKK3
QRIVGYIACTHLHAP	SMPD3	451	Q9NY59
PLHLACYFGHRQVVQ	OSBPL1A	51	Q9BXW6
QCVAYHLGRVRESLP	MMACHC	81	Q9Y4U1
HANTVCVNLPGLYRC	NELL1	446	Q92832
LEPGQQCLTTHAYLG	LY6G6C	41	O95867
NCYTHAFLIVPAIVG	MMD	31	Q15546
PTNVECSRYHLQRIL	RELN	2416	P78509
QVFALSTHPYGCRVI	PUM1	996	Q14671
IALYPGQAQLLSCKH	PACC1	116	Q9H813
DRHAAICNPLLYSGT	OR9G4	136	Q8NGQ1
QGCVPRHSVIRSLFY	OBSCN	6861	Q5VST9
ISVPLLAAQRHYCSQ	OR56B2P	166	Q8NGI1
LGRSHVYFIQCLTPN	MYO15B	221	Q96JP2
PILAAQRHYCSRNEI	OR56B4	166	Q8NH76
LIIHLNYCAGSQTKP	PLA2G4E	721	Q3MJ16
RYPIHQAQYSCLGVL	POM121	231	Q96HA1
CHAGVSTAYIILQLP	IL1RL2	316	Q9HB29
PVQLLQHTPCYRTAG	IL1RL2	546	Q9HB29
RLHNLYSTPRCAQQA	CBY2	61	Q8NA61
PSIHARLIGAYCGTQ	CUBN	1916	O60494
LTQRPQVGCYIHGLF	DNAH1	4156	Q9P2D7
VRNIRPSCHGVLGVY	ETFDH	451	Q16134
CVLYLHITRVQCFPG	ADCY1	651	Q08828
SLPYSHIGCRDQIIF	ARAF	506	P10398
CGTLILQARAYVGPH	ATP13A2	376	Q9NQ11
LTGTPLQNNLIEYHC	ATRX	1746	P46100
ACVRQHLPDLYAAAG	FBH1	326	Q8NFZ0
LHYVEPCLNGTLVQA	CACNA2D3	301	Q8IZS8
GHPYIVLNNTERCLA	CGNL1	51	Q0VF96
YHPGAVIRILACSAN	FBXL4	146	Q9UKA2
YVLAQTCGTRPGLHR	FCGBP	1276	Q9Y6R7
VYVLAQTCGTRPGLH	FCGBP	2476	Q9Y6R7
GQHIQLVQYLATVCP	CEP97	261	Q8IW35
TCVQHLNSYLGILDP	FASTKD1	596	Q53R41
GICTARAAQYLLHSP	ATOH1	71	Q92858
LHSCLNPIIYAFIGQ	CXCR1	296	P25024
SELICLYNEVHNLPG	CCDC30	46	Q5VVM6
CHYVNAINTAPRNIG	DENND5B	1186	Q6ZUT9
NRLCYVQSLAGHKSP	LYST	3646	Q99698
QLTSPRFQCGYVLLH	MARCHF11	361	A6NNE9
QLCSHYGQPVLSVRV	DENND4B	821	O75064
SCHCPQGYQLLATRL	EFEMP2	266	O95967
AYQAIHSGQCPAAIV	FASN	171	P49327
KLNVRTTHYTPLACG	DKC1	61	O60832
SRQHGCLPYAITIVA	DHX37	791	Q8IY37
QYHCLSAQLRPLLGD	RUBCN	131	Q92622
TVQHGAVYSLEPRLC	SDE2	61	Q6IQ49
ELYPTFIRNLGVHIC	SLC22A2	456	O15244
GLCPQGYVHTVLRDS	NKX2-3	86	Q8TAU0
AQQLLPCLGQTLYQH	CH25H	81	O95992
NCIYLNIPNKGHVLL	DDAH1	221	O94760
PSQYLCTPRQDHGLI	CDH16	671	O75309
HLVQLPNINRVSTCY	PPEF2	156	O14830
VQGSCAADLYRHPQL	PARP6	26	Q2NL67
RCAGVHISDPYNVNL	ARHGAP30	406	Q7Z6I6
YLCCVRTVGLQHPAV	PGAP3	181	Q96FM1
AGIHPLCLVSRYSQK	PGBD3	426	Q8N328
HHILVYACGNASVLP	MOXD2P	241	A6NHM9
VASYCHPQLLLNLVD	MROH2A	786	A6NES4
HNNVRCLCPAAYTGI	NTNG1	481	Q9Y2I2
LFNTYEHLLPGNARC	RETSAT	356	Q6NUM9
NLICKSGSLIEPHYQ	RUNDC1	556	Q96C34
VQRQVAHCLAAYAPR	TSGA10IP	411	Q3SY00
HGRLYLRTPGNVTNC	USH2A	2571	O75445
GQVHCVSPLLYESGR	SUSD2	111	Q9UGT4
PAGTQPCRLHLYNSL	CARS1	21	P49589
LFNHPNILRLVAYCL	STK16	71	O75716
NPRDTYCRGDQLHIL	NXPE4	106	Q6UWF7
LTQHTACQLLRTYPA	PLCE1	1776	Q9P212
GIPTHYVCVLNTANL	PIWIL2	901	Q8TC59
QYPHFRCRTNVLGSI	NARS2	141	Q96I59
INDPALRHTGLYCNQ	NCOA1	1356	Q15788
IPQITRNHSGLYACS	PSG9	381	Q00887
CRQLFHLIYGQPDVV	NBEAL2	1261	Q6ZNJ1
CLQTGYRHVPLQSLT	PLCL2	851	Q9UPR0
YALGERVRQLPCNHL	RNF126	236	Q9BV68
LTLGPQHADNIYICT	SLAMF1	196	Q13291
YLNHNCITTLRPGIF	RXFP2	191	Q8WXD0
LCVYGAGHLEQPQIS	TRGV9	16	Q99603
QYLCNVRHIFTIPGQ	TFB1M	201	Q8WVM0
TYACQQHEVLLPSGQ	SBNO2	256	Q9Y2G9
CNLQYLRLGGHCATP	NLRP7	761	Q8WX94
TAGVAQLPLHRCDIY	SEMA3A	506	Q14563
RLTEYIHCLQPATGR	CNEP1R1	16	Q8N9A8
RHPSLNGYLQCHIQL	MTRF1	11	O75570
NCSIVFNGPHLLLRA	SMYD3	211	Q9H7B4
FLLPQNGIRHCSYTA	SUCLG1	31	P53597
LCVANTHILYNPRRG	ANGEL1	386	Q9UNK9
AGQRPSIFQSLLHCL	CLCN1	761	P35523
HLITCISKYQSPGRA	CNKSR1	496	Q969H4
PVQGANYHVLRTGCF	C15orf61	71	A6NNL5
NGICAQVLPYLSQEH	TLE5	86	Q08117
LVRCNAHGEPRNYLN	RNF31	56	Q96EP0
LSYNRLRCIPVHAFN	SLIT3	806	O75094
IICGLTRITQYKNHP	PLPPR4	291	Q7Z2D5
RGNRPHIYCLEQLLQ	TNRC18	2196	O15417
TPDQLGNISLRHYLC	UHRF1BP1L	1221	A0JNW5
GNISLRHYLCNRPVG	UHRF1BP1L	1226	A0JNW5
TRIYHPNINSNGSIC	UBE2D2	71	P62837
YQLLLEHQRPSCIQG	RAPGEF3	56	O95398
HQLDNPYIVRLIGVC	ZAP70	391	P43403
YIQCHLAAPDGTRNL	XPO4	436	Q9C0E2
VVAAASLRCQNYGIP	UBA7	821	P41226
HVRSHLGISPYQCNI	RREB1	661	Q92766
GVCGLTQITQYRSHP	PLPPR3	246	Q6T4P5
LCYILTAHPNLGQID	SPIDR	601	Q14159
LKHLFPVQNGALYCV	MRPL42	16	Q9Y6G3
TPGESLHGYRICIQA	TMEM214	211	Q6NUQ4
TRIYHPNINSNGSIC	UBE2D3	71	P61077
PNTRHCLYGLDADLI	XRN1	196	Q8IZH2
PQVLRYHVVACHQLL	STAB2	1656	Q8WWQ8
YRCQLFIQPAGILEH	VPS13C	2586	Q709C8
YQPRIHLVRAAQLCS	TBX6	216	O95947
CHYSSVQVPRRGAIL	TTTY12	31	Q9BZ98
VNSRYSCLVAGPHQR	POLR1F	41	Q3B726
IQGLQINDYVCHPVL	RALGAPB	546	Q86X10
YRCIGLQKQQHLCSP	TAMM41	411	Q96BW9
TLRNLQPHDAGLYQC	TREM2	96	Q9NZC2
GPAVNHLYVCSICQV	USP20	771	Q9Y2K6
YLKHVCQPGRNTIQI	ZMIZ2	511	Q8NF64
GIICHFCKRNSLPQY	ZMYM2	581	Q9UBW7
CGRRFAYPSLLAIHQ	ZNF689	266	Q96CS4
LGHCELYGTNIPAVI	TTC30A	616	Q86WT1
LCAYTNPIRKGLAAH	ZNF462	1701	Q96JM2
YQGRLAVTTHGLPCL	F2	221	P00734
INHYPNGVVTVNCAR	POSTN	196	Q15063
LQAPVGSSILVQCHY	TREML1	26	Q86YW5
NYLCDSPSHVRGQQV	TLR2	561	O60603
TPYCGLRRAVQIVLH	PRSS16	326	Q9NQE7
AGVPLATLCSNLYHR	SLFN5	106	Q08AF3
LLQAYRFHACVLQLP	TERT	1006	O14746
SGALPAEHCINIYQR	TKTL1	161	P51854
LRVQHLHTPGCYQEL	TBC1D2	641	Q9BYX2
LHTPGCYQELLSRGQ	TBC1D2	646	Q9BYX2
YHFSIQGRTVCQGPL	TMEM249	121	Q2WGJ8
QGRTVCQGPLHLVYV	TMEM249	126	Q2WGJ8
CQGPLHLVYVRLALS	TMEM249	131	Q2WGJ8
GTQVCLRNNPLYHAG	UBR5	531	O95071
NIYPDGRVCISILHA	UBE2G2	81	P60604
YGIVCDASLHISNPR	VWA5B1	571	Q5TIE3
PCHAQRVLQALNAYR	KLHL35	21	Q6PF15
RGHIYLNVISSPNCD	LRIG2	776	O94898